Liu Dan-Yang, Zhong Dong-Ling, Li Juan, Jin Rong-Jiang
School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Medicine (Baltimore). 2020 Feb;99(6):e18932. doi: 10.1097/MD.0000000000018932.
Spasticity is one of the manifestations of motor dysfunction in upper motor neuron syndrome, which is characterized by increased muscle tone. Spasticity seriously affects the motor function and activity of daily life of patients. Some studies have shown that extracorporeal shock wave therapy (ESWT) can relieve spasticity in recent years. However, the effectiveness and safety of ESWT on spasticity after motor neuron injury have not been confirmed. The purpose of this systematic review (SR) is to evaluate the effectiveness and safety of ESWT on spasticity after upper motor neuron injury.
We will search China National Knowledge Infrastructure (CNKI), the Chinese Science and Technology Periodical Database (VIP), Wan Fang Data, China Biology Medicine (CBM), PubMed, Embase, The Cochrane Library, and Web of Science systematically from their inception dates through October 2019 to obtain randomized controlled trials (RCTs) using ESWT to relieve spasticity in patients after upper motor neuron injury. The primary outcome will be the Modified Ashworth Scale (MAS). Secondary outcomes will include Composite Spasticity Scale (CSS), Spasm Frequency Scale, Modified Tardieu Scale (MTS), electrophysiological study (ratio of maximum H reflex to maximum M response, root mean square value, integrated electromyogram, co-contraction ratio, etc.), or other spasticity-related outcomes. In addition, adverse events will also be assessed as safety measurement. Study selection, data extraction, and quality assessment will be performed independently by 2 reviewers. Assessment of risk of bias and data synthesis will be performed using Review Manager software (RevMan, version 5.3.5) and R (version 3.6.1) software.
We will synthesize current studies to evaluate the effectiveness and safety of ESWT on spasticity after upper motor neuron injury.
Our study will provide evidence of ESWT on spasticity after upper motor neuron injury.
The ethical approval is not required since SR is based on published studies. The results of this SR will be published in a peer-reviewed scientific journal according to the Preferred Reporting Item for Systematic Review and Meta-analysis (PRISMA) guidelines.
CRD42019131059.
痉挛是上运动神经元综合征运动功能障碍的表现之一,其特征为肌张力增加。痉挛严重影响患者的运动功能和日常生活活动。近年来,一些研究表明体外冲击波疗法(ESWT)可缓解痉挛。然而,ESWT对运动神经元损伤后痉挛的有效性和安全性尚未得到证实。本系统评价(SR)的目的是评估ESWT对上运动神经元损伤后痉挛的有效性和安全性。
我们将从中国知网(CNKI)、维普中文科技期刊数据库(VIP)、万方数据、中国生物医学文献数据库(CBM)、PubMed、Embase、考克兰图书馆和Web of Science自创建之日起至2019年10月进行系统检索,以获取使用ESWT缓解上运动神经元损伤后患者痉挛的随机对照试验(RCT)。主要结局将是改良Ashworth量表(MAS)。次要结局将包括综合痉挛量表(CSS)、痉挛频率量表、改良Tardieu量表(MTS)、电生理研究(最大H反射与最大M反应之比、均方根值、肌电图积分、共同收缩率等)或其他与痉挛相关的结局。此外,不良事件也将作为安全性指标进行评估。研究选择、数据提取和质量评估将由2名评价者独立进行。使用Review Manager软件(RevMan,版本5.3.5)和R(版本3.6.1)软件进行偏倚风险评估和数据合成。
我们将综合当前研究以评估ESWT对上运动神经元损伤后痉挛的有效性和安全性。
我们的研究将为ESWT对上运动神经元损伤后痉挛的作用提供证据。
由于本系统评价基于已发表的研究,因此无需伦理批准。本系统评价的结果将根据系统评价和Meta分析的首选报告项目(PRISMA)指南发表在同行评审的科学期刊上。
PROSPERO注册号:CRD42019131059。